Trials / Completed
CompletedNCT00359840
A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor
A Randomized, Dose - Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
To assess the clinical effective dose of KRN321 administered with once triweekly schedule.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | darbepoetin alfa |
Timeline
- Start date
- 2006-07-01
- Primary completion
- 2007-09-01
- First posted
- 2006-08-03
- Last updated
- 2012-08-31
Locations
8 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00359840. Inclusion in this directory is not an endorsement.